Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease.
about
Infectious and coronary artery diseaseRole of Helicobacter pylori infection in pathogenesis of atherosclerosisContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study.Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients.Helicobacter pylori: Does it add to risk of coronary artery disease.An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis.Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007-2008.Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosisSeroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TXAssociation of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: the Athero Gene study.Cardiac gene expression and systemic cytokine profile are complementary in a murine model of post-ischemic heart failureT helper type 1 lymphocytes drive inflammation in human atherosclerotic lesionsInflamed by the flames? The impact of terrorism and war on immunity.Acute coronary syndrome and chronic infection in the Cork coronary care case-control study.Helicobacter pylori and coronary heart disease: which directions for future studies?Chlamydia pneumoniae and coronary artery disease: legitimized linkages?No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis.Detection of herplex simplex virus-1 and -2 in cardiac myxomasmiRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery DiseaseEarly cardiac allograft vasculopathy: are the viruses to blame?Mechanisms involved in the association between periodontal diseases and cardiovascular diseasePlasmacytoid dendritic cells in atherosclerosis.The interaction of bacterial pathogens with platelets.Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging StudiesPrognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study.TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophagesMolecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery diseaseIndividual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.The association of ventricular tachycardia and endothelial dysfunction in the setting of acute myocardial infarction with ST elevation.Cytomegalovirus infection and atherosclerosis in candidate of coronary artery bypass graft.Infectious burden and atherosclerosis: A clinical issue.Association of pathogen burden and hypertension: the Persian Gulf Healthy Heart Study.Mannose-binding lectin as a risk factor for acute coronary syndromes.Elevated infection parameters and infection symptoms predict an acute coronary event.Enterovirus, mycoplasma and other infections as predictors for myocardial infarction.Pro-inflammatory genetic markers of atherosclerosis.
P2860
Q26750409-F74ED9AE-4F54-4C23-B946-C8DCBA496351Q27002402-B142EB86-3C07-4A63-82B0-40C9A327582EQ30318502-710C1201-8D23-44C3-A9A1-095877CB70DCQ30319434-23377443-9566-41AC-A2E3-29547AEB5807Q30574830-A5FB0FFA-0557-4EF7-8663-2837F753A9BFQ31082179-3715BBEF-1F65-406D-821C-F52700C6C18EQ33420062-44E7BD43-FBE1-4386-8371-61F5FDE10D07Q33763278-89F591DF-026F-42A0-8128-18D444357DB1Q33904071-19DF07CB-B446-4783-BFB4-A7CA40618F5EQ33942966-4636AFC2-EDAB-4073-897E-74948E3B49BAQ34054025-76097315-7271-4EA3-AC70-2BAC6C2D6A9FQ34471057-79BBE6BD-C322-4E2B-A451-8BAA58A07AE1Q34546289-046612E6-2A36-4741-937D-3B123537D97AQ35143874-6BA8B18B-AB6A-4F42-BAD0-F197F58B76B9Q35384977-499654F9-05CD-4292-87E6-B546936B1409Q35583359-FB83A948-4A94-4DF7-8188-86D44178C201Q35592372-162FB2C3-0F1F-482B-B571-F28E53BA2D8BQ35696285-5D62B911-19E4-4D91-8A2C-BE13D71E6CB6Q35770386-45BD998C-E5EA-4360-8AA7-3167CCFA68ACQ35830082-E00D4672-F224-49C1-BF4A-A56E521698FAQ35882504-74838EFD-9FAF-4FB6-823A-55FFD351273EQ36014749-80BDE61E-E915-4DAC-B3C8-574F79F58412Q36026069-C93D8215-5575-42DA-A78E-A55F895A1EDBQ36064574-F46E851A-242E-4804-88D7-AAC60AACA83DQ36482515-26D7EF6A-F00D-4DB8-9A23-C81A702932D0Q36848196-9188C33A-352F-4060-8F55-45FE329B2326Q36940615-8753309C-98C8-4995-9695-00489B8D9F36Q37041781-1CBD34E5-F1AA-4BB2-9196-09D088A02356Q37196471-134A7CB2-3E25-4A91-876B-CCABEFFCA909Q37222713-F270DD15-7B93-4602-802B-867B19E2E6EBQ37238669-6AB24CB4-57BA-43D2-998B-6AB8C07D74C5Q37320829-5A5A8C27-9052-47D6-AC43-E1E03A29E53DQ37367173-32E23740-53B3-4480-9B74-0A43EA35AE05Q37841266-DB99F3E4-D78C-4286-B1BC-0F1F861D3ED5Q37843968-F0382B47-A5D3-44C2-A353-345E633443E5Q37846433-EEA3F46C-0618-4EF7-AB34-F0B09DBF6483Q37854397-823A4701-C2FF-487B-88EB-A8624BD7E5F7Q37855841-1EE3AB32-A72E-4D7A-825E-9FCF53337DF3Q37870396-5A66CFCB-427A-4E5B-98A6-A32B24F26BD9Q38099537-24A53E32-3C25-4BFA-9E22-2B150F8FB240
P2860
Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of viral and bacterial ...... with coronary artery disease.
@en
Impact of viral and bacterial ...... with coronary artery disease.
@nl
type
label
Impact of viral and bacterial ...... with coronary artery disease.
@en
Impact of viral and bacterial ...... with coronary artery disease.
@nl
prefLabel
Impact of viral and bacterial ...... with coronary artery disease.
@en
Impact of viral and bacterial ...... with coronary artery disease.
@nl
P2093
P356
P1433
P1476
Impact of viral and bacterial ...... with coronary artery disease.
@en
P2093
AutoGene Investigators
H J Rupprecht
S Blankenberg
W Prellwitz
W Schlumberger
P356
10.1161/HC2601.091703
P407
P577
2001-07-01T00:00:00Z